Xolair 150mg Injection
Prescription Required
Product introduction
Xolair 150mg Injection is a monoclonal antibody. It is used in the treatment of moderate to severe asthma in both adults and children. It eases the symptoms of asthma such as wheezing, breathlessness, tightness in your chest, and coughing.
It is used in bronchial asthma
It is used in bronchial asthma
Uses of Xolair Injection
Benefits of Xolair Injection
In Asthma
Xolair 150mg Injection is used to treat the symptoms of asthma such as tightness in your chest, wheezing, breathlessness and coughing. This means you can carry out your daily activities more easily and more confidently. It may take a few weeks for this medicine to show full effects. It is given as an injection by a doctor or nurse and should not be self-administered. Taking this medicine enables you to live your life more freely without worrying so much about things that set off your symptoms.
Side effects of Xolair Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Xolair
- Joint pain
- Pain
- Fatigue
- Dizziness
- Fracture
- Itching
- Dermatitis
- Upper abdominal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Ear pain
How to use Xolair Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
SAFE
Consuming alcohol with Xolair 150mg Injection does not cause any harmful side effects.
Pregnancy
SAFE IF PRESCRIBED
Xolair 150mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CONSULT YOUR DOCTOR
Xolair 150mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Xolair 150mg Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Xolair 150mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Xolair 150mg Injection may not be needed in these patients. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Xolair 150mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Xolair 150mg Injection may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Xolair 150mg Injection
βΉ32590.0/Injection
Bolstran 150mg Injection
Cipla Ltd
βΉ10500/injection
68% cheaper
Omalirel Injection
Reliance Life Sciences
βΉ13145/injection
60% cheaper
Emzumab 150mg Injection
Cipla Ltd
βΉ10500/injection
68% cheaper
Quick tips
- Xolair 150mg Injection is used for the treatment of moderate to severe asthma.
- Seek immediate medical help if you experience symptoms like wheezing, shortness of breath, cough, chest tightness, swelling of the throat or tongue, or trouble breathing.
- Inform your doctor immediately if your asthma remains uncontrolled or worsens after initiation of treatment.
- Inform your doctor if you have any other allergies (such as food allergies or seasonal allergies).
- Let your doctor know if you are or planning to become pregnant or breastfeeding.
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
RESPIRATORY
Action Class
Anti IgE monoclonal antibodies
Patient concerns
User feedback
Patients taking Xolair 150mg Injection
Once A Month
64%
Once A Day
27%
Once A Week
9%
What are you using Xolair Injection for?
Others
75%
Asthma
25%
How much was the improvement?
Excellent
67%
Average
33%
What were the side-effects while using Xolair 150mg Injection?
Headache
33%
Fever
33%
Abdominal pai*
33%
*Abdominal pain
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Boushey HA. Drugs Used in Asthma. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 350.
- Barnes PJ. Pulmonary Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanβs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1054.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1019-20.
- Omalizumab. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2003 [revised Jul. 2016]. [Accessed 1 Apr. 2019] (online) Available from:
- Medscape. Omalizumab. [Accessed 01 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: Switzerland
Lab tests offered by us
Related/Popular tests
2,053 people viewed this recentlyMRP
βΉ32590
Inclusive of all taxes
5.0 ml in 1 packet
SOLD OUT
Variants (2)